Volume 14, Issue 11 (11-2016)
IJRM 2016, 14(11): 713-718 |
Back to browse issues page
1- Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , n.dehshirizadeh@gmail.com
3- Faculty of Pharmacy, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , n.dehshirizadeh@gmail.com
3- Faculty of Pharmacy, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (4464 Views)
Background: Cancer antigen 125 (CA-125) is a glycoprotein biomarker that is used in women with pelvic masses such as endometriosis and maybe is useful in practice of patients suspicious to endometriosis.
Objective: The aim of this study was to evaluate the association between preoperative serum CA-125 levels and clinic pathological characteristic in women with endometriosis, and find out the best serum CA-125 levels cut-off in pre and post menopause women.
Materials and Methods: Serum CA-125 levels in 87 women aged 21-54 years suspected to endometriosis with pelvic pain, dysmenorrhea, or dyspareunia were measured preoperatively. Also the association between clinic pathological characteristic and serum CA-125 level were analyzed.
Results: The mean age of women was 32.22±6.91. The mean serum CA-125 level was 49.93±4.30 U/mL. There was a significant correlation between the endometriosis stage, lesion size, adhesion score and preoperative CA-125 plasma concentration. However, we did not found significant differences in age, marital status, patient’s complaints, and pelvic pain associated to Ca125 serum level. The suggested preoperative serum cut-off levels in premenopausal and postmenopausal patients were 37 U/ml and 35 U/ml, respectively.
Conclusion: According to the results, preoperative serum CA-125 is an important predictor for patients with endometriosis and it should be taken into consideration when surgical management is suspected, especially if stage of disease, lesion size and adhesion score are undertaken.
Objective: The aim of this study was to evaluate the association between preoperative serum CA-125 levels and clinic pathological characteristic in women with endometriosis, and find out the best serum CA-125 levels cut-off in pre and post menopause women.
Materials and Methods: Serum CA-125 levels in 87 women aged 21-54 years suspected to endometriosis with pelvic pain, dysmenorrhea, or dyspareunia were measured preoperatively. Also the association between clinic pathological characteristic and serum CA-125 level were analyzed.
Results: The mean age of women was 32.22±6.91. The mean serum CA-125 level was 49.93±4.30 U/mL. There was a significant correlation between the endometriosis stage, lesion size, adhesion score and preoperative CA-125 plasma concentration. However, we did not found significant differences in age, marital status, patient’s complaints, and pelvic pain associated to Ca125 serum level. The suggested preoperative serum cut-off levels in premenopausal and postmenopausal patients were 37 U/ml and 35 U/ml, respectively.
Conclusion: According to the results, preoperative serum CA-125 is an important predictor for patients with endometriosis and it should be taken into consideration when surgical management is suspected, especially if stage of disease, lesion size and adhesion score are undertaken.
Type of Study: Original Article |
References
1. Hirsch M, Duffy JM, Kusznir JO, Davis CJ, Plana MN, Khan KS. International Collaboration to Harmonize Outcomes and Measures for Endometriosis. Variation in outcome reporting in endometriosis trials: a systematic review. Am J Obstet Gynecol 2016; 214: 452- 464. [DOI:10.1016/j.ajog.2015.12.039]
2. Barbieri RL, Niloff JM, Bast RC Jr, Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986; 45: 630-634. [DOI:10.1016/S0015-0282(16)49333-7]
3. Aflatoonian A, Rahmani E, Rahsepar M. Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized Clinical Trial. Iran J Reprod Med 2013; 11: 179-184
4. Jiang T, Huang L, Zhang S. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer. BMC Cancer 2015; 15: 1260-1267. [DOI:10.1186/s12885-015-1260-7]
5. Pittaway DE, Rondinone D, Miller KA, Barnes K. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis. Fertil Steril 1995; 64: 321-324. [DOI:10.1016/S0015-0282(16)57730-9]
6. Koninckx PR. Is mild endometriosis a condition occurring intermittently in all women? Hum Reprod 1994; 9: 2202-2205. [DOI:10.1093/oxfordjournals.humrep.a138419]
7. Szubert M, Suzin J, Wierzbowski T, Kowalczyk-Amico K. CA-125 concentration in serum and peritoneal fluid in patients with endometriosis- preliminary results. Arch Med Sci 2012; 3: 504-508. [DOI:10.5114/aoms.2012.29529]
8. Shiau CS, Chang MY, Chiang CH, Hsieh CC, Hsieh TT. Ovarian endometrioma associated with very high serum CA‐125 levels. Chang Gung Med J 2003; 26: 695-699.
9. Chen YL, Huang CY, Chien TY, Huang SH, Wu CJ, Ho CM. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Aust N Z J Obstet Gynaecol 2011; 51: 397-402. [DOI:10.1111/j.1479-828X.2011.01325.x]
10. Kim HS, Park CY, Lee JM et al. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi- center study. Gynecol Oncol 2010; 118: 283- 288. [DOI:10.1016/j.ygyno.2010.04.018]
11. Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH. Preoperative serum CA-125 levels in treating endometrial cancer. J Reprod Med 2005; 50: 585-590.
12. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 2006; 85: 1501-1505. [DOI:10.1080/00016340601022777]
13. Amaral VF, Ferriani RA, Sá MF, Nogueira AA, Rosa e Silva JC, Rosa e Silva AC, et al. Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis. Sao Paulo Med J 2006; 124: 223-227. [DOI:10.1590/S1516-31802006000400010]
14. Emin U, Tayfun G, Cantekin I, Ozlem UB, Umit B, Leyla M: Tumor markers in mature cystic teratomas of the ovary. Arch Gynecol Obstet 2009; 279: 145-147. [DOI:10.1007/s00404-008-0688-2]
15. Ramos I, Podgaec S, Abrão M, Oliveira R, Baracat E. Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study. Revista da Associação Médica Brasileira (English Edition) 2012; 58: 26-32. [DOI:10.1016/S2255-4823(12)70151-0]
16. Cho S, Cho H, Nam A, Kim HY, Choi YS, Park KH, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril 2008; 90: 2073-2079. [DOI:10.1016/j.fertnstert.2008.03.061]
17. Abrão MS, Gonçalves MOC, Dias Jr JA, Podgaec S, Chamie LP, Blasbalg R. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007; 22: 3092-3097. [DOI:10.1093/humrep/dem187]
18. Cheng YM, Wang ST, Chou CY. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99: 375-380.
19. Garzetti GG, Ciavattini A, Tranquilli AL, Arduini D, Romanini C. Serum CA-125 concentration in endometriosis patients: role of pelvic and peritoneal irritation. Gynecol Endocrinol 1994; 8: 27-31. [DOI:10.3109/09513599409028454]
20. Kukura V, Zaninovic I, Hrdina B. Concentrations of CA 125 tumor marker in endometrial carcinoma. Gynecol Oncol 1990; 37: 388-389. [DOI:10.1016/0090-8258(90)90373-S]
21. Takami M, Sakamoto H, Ohtani K, Takami T, Satoh K. An evaluation of CA 125 levels in 291 normal postmenopausal and 20 endometrial adenocarcinoma-bearing women before and after surgery. Cancer Lett 1997; 121: 69-72. [DOI:10.1016/S0304-3835(97)00332-7]
22. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta 2004; 340: 41-56. [DOI:10.1016/j.cccn.2003.10.021]
23. Karimi-Zarchi M, Baghdadabad A, Baghdadabad MR, Zahir ShT, Abadi RD, Teimoori S, et al. Evaluation of serum CA 125 level and its relation to surgical, histopathologic and ultrasonographic findings in patients with pelvic mass. Eur J Gynaecol Oncol 2014; 35: 67-71.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |